BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 27777528)

  • 1. Staged High-Risk Percutaneous Coronary Intervention with Impella Support after On-Pump Transcatheter Aortic Valve Replacement.
    Arora S; Bahekar AA
    Tex Heart Inst J; 2016 Oct; 43(5):423-427. PubMed ID: 27777528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of complex coronary intervention in combination with percutaneous aortic valve implantation in patients with aortic stenosis using percutaneous left ventricular assist device (TandemHeart).
    Piazza N; Serruys PW; de Jaegere P
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):161-6. PubMed ID: 19160444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rationale for Performance of Coronary Angiography and Stenting Before Transcatheter Aortic Valve Replacement: From the Interventional Section Leadership Council of the American College of Cardiology.
    Ramee S; Anwaruddin S; Kumar G; Piana RN; Babaliaros V; Rab T; Klein LW; ;
    JACC Cardiovasc Interv; 2016 Dec; 9(23):2371-2375. PubMed ID: 27931592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed-Onset Left Main Coronary Artery Obstruction More than 24 Hours after Balloon-Expandable Transcatheter Aortic Valve Replacement.
    Isawa T; Tada N; Ootomo T
    Tex Heart Inst J; 2016 Oct; 43(5):441-445. PubMed ID: 27777533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.
    Millan-Iturbe O; Sawaya FJ; Lønborg J; Chow DHF; Bieliauskas G; Engstrøm T; Søndergaard L; De Backer O
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):818-826. PubMed ID: 29214718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of left main coronary artery obstruction after transcatheter aortic valve replacement utilizing a periscope approach.
    Drexel T; Helmer G; Garcia S; Raveendran G
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1444-1448. PubMed ID: 28941149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Coronary Intervention of Complex Calcific Coronary Lesions Utilizing Orbital Atherectomy Prior to Transcatheter Aortic Valve Replacement.
    Beohar N; Mohammed N; Kherada N; Igyarto Z; Martinsen BJ
    Cardiovasc Revasc Med; 2022 Apr; 37():82-85. PubMed ID: 34261617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous TAVR and Left Main "Chimney" Stenting in a Patient With Low Left Main Height.
    Spaziano M; Akodad M; Hovasse T; Lefèvre T; Bouvier E; Chevalier B
    JACC Cardiovasc Interv; 2017 Oct; 10(20):e185-e187. PubMed ID: 28964762
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel Mechanism of Delayed Coronary Obstruction after Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis: "Uppercut Phenomenon".
    Shishido K; Yamanaka F; Noguchi K; Ota T; Fushimi T; Saito S
    Cardiovasc Revasc Med; 2019 Nov; 20(11S):79-84. PubMed ID: 31350193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed Left Main Narrowing From the Native Left Aortic Valve Leaflet After Transcatheter Aortic Valve Replacement With the Lotus Valve: A Successful Intervention for a Novel Complication.
    Glassy MS; Southard JA; Stripe BR; Low RI
    JACC Cardiovasc Interv; 2018 May; 11(9):e73-e74. PubMed ID: 29680217
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful percutaneous coronary intervention after implantation of a CoreValve percutaneous aortic valve.
    Geist V; Sherif MA; Khattab AA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):61-7. PubMed ID: 19089940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self-expandable bioprosthetic valve.
    Htun WW; Grines C; Schreiber T
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1339-1344. PubMed ID: 28988450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Successful Reopening of Left Main Coronary Artery Occlusion After Transcatheter Aortic Valve Replacement.
    Yoshida M; Saito N; Imai M; Tsujimura A; Sakamoto K; Toyota T; Nakatsu T; Watanabe H; Taniguchi T; Yaku H; Tazaki J; Shiomi H; Mizota T; Kato T; Yamazaki K; Kimura T
    JACC Cardiovasc Interv; 2018 Feb; 11(4):409-411. PubMed ID: 29471955
    [No Abstract]   [Full Text] [Related]  

  • 14. Subocclusive Ostial Left Main Disease After Transcatheter Aortic Implantation with Bail-Out Valve-in-Valve.
    Giordano A; Ferraro P; Biondi-Zoccai G; Corcione N
    Cardiovasc Revasc Med; 2019 Oct; 20(10):928-930. PubMed ID: 31060968
    [No Abstract]   [Full Text] [Related]  

  • 15. Should We Protect the Coronary Artery During Transcatheter Aortic Valve Replacement in Quadricuspid Valve Patients?
    Takahashi M; Aizawa K; Oba Y; Funayama H; Kawahito K; Kario K
    JACC Cardiovasc Interv; 2020 Jun; 13(12):1492-1494. PubMed ID: 32473884
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylactic percutaneous circulatory support in high risk transcatheter aortic valve implantation.
    Castrodeza J; Serrador Frutos AM; Amat-Santos IJ; Sayago Silva I; San Román JA
    Cardiol J; 2019; 26(4):424-426. PubMed ID: 31452190
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of Impella 5.0 Prior to Transcatheter Aortic Valve Replacement in a Patient with Severe Aortic Stenosis and Cardiogenic Shock.
    Johnson DW; ErwinIII JP
    J Heart Valve Dis; 2017 Jul; 26(4):485-487. PubMed ID: 29302950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant percutaneous coronary intervention and transcatheter aortic valve replacement: safe and feasible replacement alternative approaches in high-risk patients with severe aortic stenosis and coronary artery disease.
    Salhab KF; Al Kindi AH; Lane JH; Knudson KE; Kapadia S; Roselli EE; Tuzcu ME; Svensson LG
    J Card Surg; 2013 Sep; 28(5):481-3. PubMed ID: 23869423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A contemporary and complete treatment solution for a high-risk patient with critical aortic stenosis, left ventricular thrombus, severe left ventricular dysfunction, and calcified left main stem disease.
    Yeoh J; Dworakowski R; Hill J; Byrne J
    Catheter Cardiovasc Interv; 2020 Mar; 95(4):851-854. PubMed ID: 31617327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstruction of 2 Coronary Arteries from Different Causes Immediately after Transapical Transcatheter Aortic Valve Replacement.
    Kaneko U; Koshima R; Doi H; Fujita T
    Tex Heart Inst J; 2020 Feb; 47(1):30-34. PubMed ID: 32148450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.